Cyanopindolol hemifumarate

This small molecule research compound acts as a dual antagonist, targeting both serotonin receptors (5-HT1A and 5-HT1B) and beta-adrenergic receptors. It is utilized in neuroscience and cardiovascular research to investigate receptor function and interactions in both in vitro binding assays and in vivo behavioral or physiological models.